Targeting RAS mutants in malignancies: successes, failures, and reasons for hope.
Yang H, Zhou X, Fu D, Le C, Wang J, Zhou Q, Liu X, Yuan Y, Ding K, Xiao Q.
Yang H, et al. Among authors: zhou x, zhou q.
Cancer Commun (Lond). 2023 Jan;43(1):42-74. doi: 10.1002/cac2.12377. Epub 2022 Oct 31.
Cancer Commun (Lond). 2023.
PMID: 36316602
Free PMC article.
Review.